Results 171 to 180 of about 247,667 (242)
Endocannabinoid system modulation for visceral abdominal pain in inflammatory bowel disease and irritable bowel syndrome: A protocol for systematic review and meta-analysis. [PDF]
Lane RM +5 more
europepmc +1 more source
Editorial: Neurobiological basis of substance use disorders: new findings and perspectives. [PDF]
Favoretto CA +3 more
europepmc +1 more source
Multiple Roles of Cannabinoids in the Olfactory System. [PDF]
Heinbockel T, Brown EA.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Enantio-specific Allosteric Modulation of Cannabinoid 1 Receptor
ACS Chemical Neuroscience, 2017The cannabinoid 1 receptor (CB1R) is one of the most widely expressed metabotropic G protein-coupled receptors in brain, and its participation in various (patho)physiological processes has made CB1R activation a viable therapeutic modality.
R. Laprairie +10 more
semanticscholar +3 more sources
Selective cannabinoid receptor 2 modulators: a patent review 2009 – present
Expert Opinion on Therapeutic Patents, 2012Doris Riether
exaly +2 more sources
Allosteric Modulation of the Cannabinoid CB1 Receptor
Molecular Pharmacology, 2005We investigated the pharmacology of three novel compounds, Org 27569 (5-chloro-3-ethyl-1H-indole-2-carboxylic acid [2-(4-piperidin-1-yl-phenyl)-ethyl]-amide), Org 27759 (3-ethyl-5-fluoro-1H-indole-2-carboxylic acid [2-94-dimethylamino-phenyl)-ethyl]-amide), and Org 29647 (5-chloro-3-ethyl-1H-indole-2-carboxylic acid (1-benzyl-pyrrolidin-3-yl)-amide, 2 ...
Martin R, Price +16 more
openaire +2 more sources
Modulation of cannabinoid receptor signaling by endocannabinoids
2022Abstract Endocannabinoids (eCBs) are endogenous lipid molecules that activate the cannabinoid receptor 1 (CB1), a G protein coupled receptor (GPCR) that signals primarily through the G i/o family of G proteins to regulate neurotransmitter release.
Kaavya Krishna Kumar +14 more
openaire +1 more source

